While very low-count MBL hardly ever progresses to CLL, superior-count MBL progresses to CLL necessitating therapy in a level of 1% to 2% annually. Significant-depend MBL is distinguished from Rai 0 CLL depending on if the B-mobile count is earlier mentioned or beneath 5 × 109/L. Though folks